Annual FCF
-$5.15 M
+$903.19 K+14.93%
31 August 2024
Summary:
Lexaria Bioscience annual free cash flow is currently -$5.15 million, with the most recent change of +$903.19 thousand (+14.93%) on 31 August 2024. During the last 3 years, it has fallen by -$1.08 million (-26.50%). LEXX annual FCF is now -2343.94% below its all-time high of $229.40 thousand, reached on 31 October 2013.LEXX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.96 M
-$673.15 K-52.26%
31 August 2024
Summary:
Lexaria Bioscience quarterly free cash flow is currently -$1.96 million, with the most recent change of -$673.15 thousand (-52.26%) on 31 August 2024. Over the past year, it has dropped by -$739.55 thousand (-60.53%). LEXX quarterly FCF is now -1210.56% below its all-time high of $176.60 thousand, reached on 31 October 2012.LEXX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$5.15 M
-$271.15 K-5.56%
31 August 2024
Summary:
Lexaria Bioscience TTM free cash flow is currently -$5.15 million, with the most recent change of -$271.15 thousand (-5.56%) on 31 August 2024. Over the past year, it has increased by +$844.75 thousand (+14.10%). LEXX TTM FCF is now -1534.28% below its all-time high of $358.90 thousand, reached on 31 July 2013.LEXX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEXX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.9% | -60.5% | +14.1% |
| 3 y3 years | -26.5% | -60.2% | -14.9% |
| 5 y5 years | -36.4% | -249.7% | -42.8% |
LEXX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -26.5% | +14.9% | -189.9% | at low | -26.5% | +14.9% |
| 5 y | 5 years | -94.1% | +14.9% | -249.7% | at low | -94.1% | +14.9% |
| alltime | all time | -2343.9% | +14.9% | -1210.6% | at low | -1534.3% | +14.9% |
Lexaria Bioscience Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2024 | -$5.15 M(-14.9%) | -$1.96 M(+52.3%) | -$5.15 M(+5.6%) |
| May 2024 | - | -$1.29 M(+90.4%) | -$4.88 M(-9.8%) |
| Feb 2024 | - | -$676.60 K(-44.6%) | -$5.41 M(-9.8%) |
| Nov 2023 | - | -$1.22 M(-27.7%) | -$5.99 M(-1.0%) |
| Aug 2023 | -$6.05 M(+19.6%) | -$1.69 M(-7.1%) | -$6.05 M(+8.3%) |
| May 2023 | - | -$1.82 M(+44.3%) | -$5.59 M(+10.3%) |
| Feb 2023 | - | -$1.26 M(-1.5%) | -$5.07 M(-1.0%) |
| Nov 2022 | - | -$1.28 M(+4.4%) | -$5.12 M(+1.1%) |
| Aug 2022 | -$5.06 M(+24.3%) | -$1.23 M(-5.4%) | -$5.06 M(+2.3%) |
| May 2022 | - | -$1.30 M(-1.1%) | -$4.95 M(+1.4%) |
| Feb 2022 | - | -$1.31 M(+7.1%) | -$4.88 M(+8.9%) |
| Nov 2021 | - | -$1.22 M(+10.1%) | -$4.48 M(+10.1%) |
| Aug 2021 | -$4.07 M(+53.4%) | -$1.11 M(-9.4%) | -$4.07 M(+12.7%) |
| May 2021 | - | -$1.23 M(+34.3%) | -$3.61 M(+17.7%) |
| Feb 2021 | - | -$914.20 K(+12.1%) | -$3.07 M(+5.5%) |
| Nov 2020 | - | -$815.30 K(+24.9%) | -$2.91 M(+9.6%) |
| Aug 2020 | -$2.65 M(-29.7%) | -$653.00 K(-4.6%) | -$2.65 M(-4.2%) |
| May 2020 | - | -$684.80 K(-9.2%) | -$2.77 M(-19.1%) |
| Feb 2020 | - | -$753.90 K(+34.4%) | -$3.42 M(-5.0%) |
| Nov 2019 | - | -$560.80 K(-27.1%) | -$3.60 M(-4.5%) |
| Aug 2019 | -$3.77 M(+45.0%) | -$769.70 K(-42.6%) | -$3.77 M(-2.4%) |
| May 2019 | - | -$1.34 M(+43.7%) | -$3.87 M(+24.2%) |
| Feb 2019 | - | -$932.90 K(+27.5%) | -$3.11 M(+11.3%) |
| Nov 2018 | - | -$731.50 K(-15.3%) | -$2.80 M(+7.5%) |
| Aug 2018 | -$2.60 M(+67.4%) | -$863.80 K(+47.3%) | -$2.60 M(+24.4%) |
| May 2018 | - | -$586.30 K(-5.0%) | -$2.09 M(-0.8%) |
| Feb 2018 | - | -$617.20 K(+15.1%) | -$2.11 M(+6.7%) |
| Nov 2017 | - | -$536.00 K(+51.7%) | -$1.98 M(+27.1%) |
| Aug 2017 | -$1.56 M(+128.4%) | -$353.30 K(-41.5%) | -$1.56 M(+6.0%) |
| May 2017 | - | -$603.50 K(+24.7%) | -$1.47 M(+50.9%) |
| Feb 2017 | - | -$484.10 K(+322.1%) | -$972.90 K(+66.7%) |
| Nov 2016 | - | -$114.70 K(-56.8%) | -$583.60 K(-14.3%) |
| Aug 2016 | -$681.00 K(-55.7%) | -$265.50 K(+144.5%) | -$680.90 K(-31.4%) |
| May 2016 | - | -$108.60 K(+14.6%) | -$992.30 K(-24.3%) |
| Feb 2016 | - | -$94.80 K(-55.3%) | -$1.31 M(-16.9%) |
| Nov 2015 | - | -$212.00 K(-63.3%) | -$1.58 M(+2.5%) |
| Aug 2015 | -$1.54 M | -$576.90 K(+35.1%) | -$1.54 M(+29.9%) |
| May 2015 | - | -$427.00 K(+18.3%) | -$1.18 M(+33.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2015 | - | -$360.90 K(+108.4%) | -$885.30 K(+68.8%) |
| Nov 2014 | - | -$173.20 K(-22.3%) | -$524.40 K(+24.5%) |
| Aug 2014 | -$584.40 K(-354.8%) | - | - |
| July 2014 | - | -$222.90 K(+73.7%) | -$421.10 K(+205.1%) |
| Apr 2014 | - | -$128.30 K(+9.8%) | -$138.00 K(-258.4%) |
| Jan 2014 | - | -$116.90 K(-348.7%) | $87.10 K(-62.0%) |
| Oct 2013 | $229.40 K(-266.0%) | $47.00 K(-21.9%) | $229.30 K(-36.1%) |
| July 2013 | - | $60.20 K(-37.8%) | $358.90 K(+148.2%) |
| Apr 2013 | - | $96.80 K(+282.6%) | $144.60 K(-754.3%) |
| Jan 2013 | - | $25.30 K(-85.7%) | -$22.10 K(-84.0%) |
| Oct 2012 | -$138.20 K(-84.5%) | $176.60 K(-214.6%) | -$138.10 K(-81.4%) |
| July 2012 | - | -$154.10 K(+120.5%) | -$743.30 K(+20.4%) |
| Apr 2012 | - | -$69.90 K(-22.9%) | -$617.30 K(-7.9%) |
| Jan 2012 | - | -$90.70 K(-78.8%) | -$670.50 K(-24.9%) |
| Oct 2011 | -$892.80 K(+45.0%) | -$428.60 K(+1425.3%) | -$892.80 K(+40.1%) |
| July 2011 | - | -$28.10 K(-77.2%) | -$637.40 K(+7.3%) |
| Apr 2011 | - | -$123.10 K(-60.7%) | -$594.20 K(+3.2%) |
| Jan 2011 | - | -$313.00 K(+80.7%) | -$575.70 K(+74.2%) |
| Oct 2010 | -$615.60 K(+136.6%) | -$173.20 K(-1247.0%) | -$330.40 K(+254.9%) |
| July 2010 | - | $15.10 K(-114.4%) | -$93.10 K(-44.2%) |
| Apr 2010 | - | -$104.60 K(+54.5%) | -$166.80 K(-26.6%) |
| Jan 2010 | - | -$67.70 K(-205.6%) | -$227.10 K(-12.7%) |
| Oct 2009 | -$260.20 K(-53.0%) | $64.10 K(-209.4%) | -$260.20 K(-41.3%) |
| July 2009 | - | -$58.60 K(-64.5%) | -$442.90 K(+1.0%) |
| Apr 2009 | - | -$164.90 K(+63.6%) | -$438.70 K(+164.6%) |
| Jan 2009 | - | -$100.80 K(-15.0%) | -$165.80 K(-70.0%) |
| Oct 2008 | -$553.40 K(-76.0%) | -$118.60 K(+118.0%) | -$553.40 K(-58.3%) |
| July 2008 | - | -$54.40 K(-150.4%) | -$1.33 M(-3.9%) |
| Apr 2008 | - | $108.00 K(-122.1%) | -$1.38 M(-28.7%) |
| Jan 2008 | - | -$488.40 K(-45.2%) | -$1.94 M(-16.0%) |
| Oct 2007 | -$2.31 M(+37.1%) | -$892.00 K(+719.1%) | -$2.31 M(+8.0%) |
| July 2007 | - | -$108.90 K(-75.7%) | -$2.14 M(+0.1%) |
| Apr 2007 | - | -$447.70 K(-47.9%) | -$2.13 M(+19.7%) |
| Jan 2007 | - | -$858.60 K(+19.1%) | -$1.78 M(+5.9%) |
| Oct 2006 | -$1.68 M(+458.3%) | -$721.20 K(+571.5%) | -$1.68 M(+75.0%) |
| July 2006 | - | -$107.40 K(+12.0%) | -$962.00 K(+12.6%) |
| Apr 2006 | - | -$95.90 K(-87.4%) | -$854.60 K(+12.6%) |
| Jan 2006 | - | -$758.70 K | -$758.70 K |
| Oct 2005 | -$301.50 K | - | - |
FAQ
- What is Lexaria Bioscience annual free cash flow?
- What is the all time high annual FCF for Lexaria Bioscience?
- What is Lexaria Bioscience annual FCF year-on-year change?
- What is Lexaria Bioscience quarterly free cash flow?
- What is the all time high quarterly FCF for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly FCF year-on-year change?
- What is Lexaria Bioscience TTM free cash flow?
- What is the all time high TTM FCF for Lexaria Bioscience?
- What is Lexaria Bioscience TTM FCF year-on-year change?
What is Lexaria Bioscience annual free cash flow?
The current annual FCF of LEXX is -$5.15 M
What is the all time high annual FCF for Lexaria Bioscience?
Lexaria Bioscience all-time high annual free cash flow is $229.40 K
What is Lexaria Bioscience annual FCF year-on-year change?
Over the past year, LEXX annual free cash flow has changed by +$903.19 K (+14.93%)
What is Lexaria Bioscience quarterly free cash flow?
The current quarterly FCF of LEXX is -$1.96 M
What is the all time high quarterly FCF for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly free cash flow is $176.60 K
What is Lexaria Bioscience quarterly FCF year-on-year change?
Over the past year, LEXX quarterly free cash flow has changed by -$739.55 K (-60.53%)
What is Lexaria Bioscience TTM free cash flow?
The current TTM FCF of LEXX is -$5.15 M
What is the all time high TTM FCF for Lexaria Bioscience?
Lexaria Bioscience all-time high TTM free cash flow is $358.90 K
What is Lexaria Bioscience TTM FCF year-on-year change?
Over the past year, LEXX TTM free cash flow has changed by +$844.75 K (+14.10%)